Structure

Physi-Chem Properties

Molecular Weight:  620.17
Volume:  617.036
LogP:  6.464
LogD:  2.695
LogS:  -3.974
# Rotatable Bonds:  3
TPSA:  181.8
# H-Bond Aceptor:  10
# H-Bond Donor:  6
# Rings:  7
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.069
Synthetic Accessibility Score:  4.52
Fsp3:  0.167
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.573
MDCK Permeability:  8.814430657366756e-06
Pgp-inhibitor:  0.058
Pgp-substrate:  0.01
Human Intestinal Absorption (HIA):  0.88
20% Bioavailability (F20%):  0.02
30% Bioavailability (F30%):  0.995

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.001
Plasma Protein Binding (PPB):  89.87665557861328%
Volume Distribution (VD):  0.422
Pgp-substrate:  21.954240798950195%

ADMET: Metabolism

CYP1A2-inhibitor:  0.419
CYP1A2-substrate:  0.196
CYP2C19-inhibitor:  0.365
CYP2C19-substrate:  0.047
CYP2C9-inhibitor:  0.654
CYP2C9-substrate:  0.61
CYP2D6-inhibitor:  0.003
CYP2D6-substrate:  0.13
CYP3A4-inhibitor:  0.101
CYP3A4-substrate:  0.064

ADMET: Excretion

Clearance (CL):  2.145
Half-life (T1/2):  0.199

ADMET: Toxicity

hERG Blockers:  0.001
Human Hepatotoxicity (H-HT):  0.904
Drug-inuced Liver Injury (DILI):  0.996
AMES Toxicity:  0.736
Rat Oral Acute Toxicity:  0.753
Maximum Recommended Daily Dose:  0.907
Skin Sensitization:  0.897
Carcinogencity:  0.474
Eye Corrosion:  0.003
Eye Irritation:  0.888
Respiratory Toxicity:  0.032

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC19273

Natural Product ID:  NPC19273
Common Name*:   Garcivilin C
IUPAC Name:   3-[(E)-2-[(1S,2R)-1,4-dimethyl-2-(1,4,5-trihydroxy-9-oxoxanthen-3-yl)cyclohex-3-en-1-yl]ethenyl]-1,4,5-trihydroxyxanthen-9-one
Synonyms:   Garcivilin C
Standard InCHIKey:  XYRCPMXSIHHGSO-VDSQSLJXSA-N
Standard InCHI:  InChI=1S/C36H28O10/c1-16-9-11-36(2,12-10-17-14-24(39)26-29(42)18-5-3-7-22(37)32(18)45-34(26)28(17)41)21(13-16)20-15-25(40)27-30(43)19-6-4-8-23(38)33(19)46-35(27)31(20)44/h3-8,10,12-15,21,37-41,44H,9,11H2,1-2H3/b12-10+/t21-,36-/m0/s1
SMILES:  CC1=C[C@@H](c2cc(c3c(=O)c4cccc(c4oc3c2O)O)O)[C@@](C)(CC1)/C=C/c1cc(c2c(=O)c3cccc(c3oc2c1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL499445
PubChem CID:   10031809
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO5638 Garcinia livingstonei Species Clusiaceae Eukaryota n.a. fruit n.a. DOI[10.1016/S0040-4020(01)89039-6]
NPO5638 Garcinia livingstonei Species Clusiaceae Eukaryota root bark n.a. n.a. PMID[16562837]
NPO5638 Garcinia livingstonei Species Clusiaceae Eukaryota n.a. fruit n.a. PMID[21028890]
NPO5638 Garcinia livingstonei Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT171 Cell Line MRC5 Homo sapiens IC50 = 52300.0 nM PMID[547539]
NPT471 Organism Trypanosoma brucei brucei Trypanosoma brucei brucei IC50 = 7700.0 nM PMID[547539]
NPT580 Organism Trypanosoma cruzi Trypanosoma cruzi IC50 = 39200.0 nM PMID[547539]
NPT1021 Organism Leishmania infantum Leishmania infantum IC50 > 64000.0 nM PMID[547539]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 > 64000.0 nM PMID[547539]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC19273 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC17884
0.9119 High Similarity NPC75069
0.8976 High Similarity NPC272560
0.8947 High Similarity NPC120102
0.8922 High Similarity NPC14662
0.8916 High Similarity NPC477840
0.8902 High Similarity NPC188967
0.8896 High Similarity NPC185526
0.8855 High Similarity NPC272064
0.8848 High Similarity NPC34089
0.8848 High Similarity NPC196179
0.8841 High Similarity NPC154304
0.8841 High Similarity NPC287458
0.8841 High Similarity NPC190487
0.8837 High Similarity NPC185275
0.8837 High Similarity NPC324742
0.8812 High Similarity NPC294502
0.8812 High Similarity NPC200221
0.881 High Similarity NPC243877
0.8795 High Similarity NPC477841
0.8788 High Similarity NPC98892
0.8779 High Similarity NPC265380
0.8765 High Similarity NPC174700
0.8757 High Similarity NPC476279
0.875 High Similarity NPC224851
0.8743 High Similarity NPC303460
0.8743 High Similarity NPC306321
0.8736 High Similarity NPC150977
0.8735 High Similarity NPC472275
0.8727 High Similarity NPC474290
0.8727 High Similarity NPC185258
0.8727 High Similarity NPC172770
0.8721 High Similarity NPC216307
0.8713 High Similarity NPC473834
0.8706 High Similarity NPC476365
0.8704 High Similarity NPC475076
0.869 High Similarity NPC259757
0.8688 High Similarity NPC46941
0.8686 High Similarity NPC154527
0.8683 High Similarity NPC470694
0.8683 High Similarity NPC219927
0.8675 High Similarity NPC200746
0.8667 High Similarity NPC129684
0.8667 High Similarity NPC112954
0.8667 High Similarity NPC187745
0.8667 High Similarity NPC181960
0.8667 High Similarity NPC96167
0.8667 High Similarity NPC299520
0.8667 High Similarity NPC469584
0.8667 High Similarity NPC245758
0.8667 High Similarity NPC161960
0.8667 High Similarity NPC472914
0.8667 High Similarity NPC222814
0.8667 High Similarity NPC304008
0.8667 High Similarity NPC472911
0.8667 High Similarity NPC472913
0.8667 High Similarity NPC79053
0.8667 High Similarity NPC472910
0.8663 High Similarity NPC99591
0.8655 High Similarity NPC257667
0.8655 High Similarity NPC186847
0.8655 High Similarity NPC472454
0.8647 High Similarity NPC188079
0.8647 High Similarity NPC476637
0.8647 High Similarity NPC475212
0.8639 High Similarity NPC171985
0.8639 High Similarity NPC320741
0.8639 High Similarity NPC251336
0.8639 High Similarity NPC472449
0.8639 High Similarity NPC37870
0.8636 High Similarity NPC226725
0.8631 High Similarity NPC220313
0.8625 High Similarity NPC209278
0.8623 High Similarity NPC472906
0.8623 High Similarity NPC266314
0.8623 High Similarity NPC29876
0.8623 High Similarity NPC234644
0.8623 High Similarity NPC167678
0.8616 High Similarity NPC59551
0.8606 High Similarity NPC115853
0.8606 High Similarity NPC274730
0.8606 High Similarity NPC472916
0.8606 High Similarity NPC191146
0.8606 High Similarity NPC138243
0.8606 High Similarity NPC68093
0.8605 High Similarity NPC149846
0.8605 High Similarity NPC82217
0.8605 High Similarity NPC216842
0.8605 High Similarity NPC476640
0.8598 High Similarity NPC206238
0.8598 High Similarity NPC292214
0.8598 High Similarity NPC271779
0.8598 High Similarity NPC88645
0.8598 High Similarity NPC167091
0.8596 High Similarity NPC72696
0.8596 High Similarity NPC103307
0.8589 High Similarity NPC251110
0.8588 High Similarity NPC470374
0.8588 High Similarity NPC470704
0.8588 High Similarity NPC295082
0.8588 High Similarity NPC478059
0.8588 High Similarity NPC476306
0.8588 High Similarity NPC478060
0.8588 High Similarity NPC470377
0.8588 High Similarity NPC471975
0.858 High Similarity NPC234052
0.858 High Similarity NPC58223
0.858 High Similarity NPC169471
0.858 High Similarity NPC72787
0.858 High Similarity NPC7688
0.858 High Similarity NPC125039
0.858 High Similarity NPC36916
0.858 High Similarity NPC36
0.858 High Similarity NPC224280
0.858 High Similarity NPC476170
0.858 High Similarity NPC7154
0.8571 High Similarity NPC25152
0.8571 High Similarity NPC140346
0.8571 High Similarity NPC206605
0.8571 High Similarity NPC83922
0.8571 High Similarity NPC47883
0.8571 High Similarity NPC472448
0.8571 High Similarity NPC149389
0.8563 High Similarity NPC297807
0.8563 High Similarity NPC204290
0.8563 High Similarity NPC139036
0.8563 High Similarity NPC235018
0.8563 High Similarity NPC45146
0.8563 High Similarity NPC471789
0.8563 High Similarity NPC188433
0.8555 High Similarity NPC287243
0.8554 High Similarity NPC210084
0.8554 High Similarity NPC474836
0.8554 High Similarity NPC262286
0.8554 High Similarity NPC300727
0.8554 High Similarity NPC180011
0.8554 High Similarity NPC48208
0.8554 High Similarity NPC219867
0.8554 High Similarity NPC474208
0.8554 High Similarity NPC475267
0.8554 High Similarity NPC36852
0.8554 High Similarity NPC162869
0.8554 High Similarity NPC183
0.8554 High Similarity NPC78225
0.8554 High Similarity NPC241904
0.8554 High Similarity NPC99597
0.8554 High Similarity NPC156057
0.8547 High Similarity NPC81332
0.8547 High Similarity NPC262580
0.8547 High Similarity NPC289396
0.8547 High Similarity NPC212038
0.8547 High Similarity NPC54098
0.8547 High Similarity NPC230619
0.8547 High Similarity NPC4200
0.8547 High Similarity NPC271848
0.8545 High Similarity NPC50715
0.8545 High Similarity NPC20830
0.8545 High Similarity NPC128863
0.8545 High Similarity NPC183597
0.8545 High Similarity NPC201136
0.8545 High Similarity NPC2928
0.8545 High Similarity NPC255807
0.8545 High Similarity NPC31018
0.8545 High Similarity NPC227325
0.8545 High Similarity NPC163780
0.8545 High Similarity NPC196439
0.8545 High Similarity NPC146165
0.8545 High Similarity NPC472909
0.8545 High Similarity NPC92659
0.8545 High Similarity NPC2476
0.8545 High Similarity NPC280339
0.8545 High Similarity NPC167815
0.8545 High Similarity NPC256612
0.8545 High Similarity NPC138360
0.8545 High Similarity NPC208197
0.8545 High Similarity NPC4455
0.8539 High Similarity NPC473618
0.8538 High Similarity NPC107627
0.8537 High Similarity NPC120537
0.8537 High Similarity NPC199100
0.8537 High Similarity NPC161277
0.8537 High Similarity NPC180234
0.8537 High Similarity NPC39007
0.8537 High Similarity NPC101996
0.8529 High Similarity NPC120593
0.8528 High Similarity NPC248102
0.8528 High Similarity NPC61620
0.8521 High Similarity NPC23298
0.8521 High Similarity NPC187491
0.8521 High Similarity NPC236132
0.8521 High Similarity NPC207690
0.8521 High Similarity NPC146134
0.8521 High Similarity NPC236521
0.8521 High Similarity NPC319200
0.8521 High Similarity NPC189473
0.8521 High Similarity NPC152659
0.8521 High Similarity NPC127415
0.8521 High Similarity NPC248638
0.8521 High Similarity NPC12461
0.8514 High Similarity NPC473785

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC19273 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.858 High Similarity NPD6166 Phase 2
0.858 High Similarity NPD6168 Clinical (unspecified phase)
0.858 High Similarity NPD6167 Clinical (unspecified phase)
0.8485 Intermediate Similarity NPD2801 Approved
0.8313 Intermediate Similarity NPD1934 Approved
0.8235 Intermediate Similarity NPD5494 Approved
0.8229 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD6959 Discontinued
0.8171 Intermediate Similarity NPD7074 Phase 3
0.8167 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8166 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8155 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8114 Intermediate Similarity NPD7054 Approved
0.8103 Intermediate Similarity NPD7473 Discontinued
0.809 Intermediate Similarity NPD8312 Approved
0.809 Intermediate Similarity NPD8313 Approved
0.8068 Intermediate Similarity NPD7472 Approved
0.8059 Intermediate Similarity NPD3882 Suspended
0.8049 Intermediate Similarity NPD1511 Approved
0.8035 Intermediate Similarity NPD6232 Discontinued
0.8011 Intermediate Similarity NPD5844 Phase 1
0.7955 Intermediate Similarity NPD3818 Discontinued
0.7952 Intermediate Similarity NPD1512 Approved
0.7941 Intermediate Similarity NPD1465 Phase 2
0.7933 Intermediate Similarity NPD7808 Phase 3
0.7933 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7921 Intermediate Similarity NPD6797 Phase 2
0.7895 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD5402 Approved
0.7877 Intermediate Similarity NPD7251 Discontinued
0.7841 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD3817 Phase 2
0.7784 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD4380 Phase 2
0.7758 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7746 Intermediate Similarity NPD7768 Phase 2
0.7701 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.768 Intermediate Similarity NPD6559 Discontinued
0.7661 Intermediate Similarity NPD6599 Discontinued
0.763 Intermediate Similarity NPD7819 Suspended
0.7622 Intermediate Similarity NPD6099 Approved
0.7622 Intermediate Similarity NPD6100 Approved
0.7616 Intermediate Similarity NPD7411 Suspended
0.7611 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7602 Intermediate Similarity NPD3226 Approved
0.76 Intermediate Similarity NPD7075 Discontinued
0.76 Intermediate Similarity NPD3749 Approved
0.7574 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD3750 Approved
0.753 Intermediate Similarity NPD1549 Phase 2
0.7515 Intermediate Similarity NPD7390 Discontinued
0.7486 Intermediate Similarity NPD3926 Phase 2
0.7485 Intermediate Similarity NPD447 Suspended
0.7485 Intermediate Similarity NPD5403 Approved
0.7473 Intermediate Similarity NPD8150 Discontinued
0.7471 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD2346 Discontinued
0.747 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7459 Intermediate Similarity NPD7228 Approved
0.7439 Intermediate Similarity NPD1607 Approved
0.7429 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD943 Approved
0.7419 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD1551 Phase 2
0.7391 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD2800 Approved
0.7368 Intermediate Similarity NPD5401 Approved
0.7368 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7363 Intermediate Similarity NPD3751 Discontinued
0.736 Intermediate Similarity NPD6234 Discontinued
0.7349 Intermediate Similarity NPD1510 Phase 2
0.7329 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD6776 Approved
0.732 Intermediate Similarity NPD6779 Approved
0.732 Intermediate Similarity NPD6780 Approved
0.732 Intermediate Similarity NPD6781 Approved
0.732 Intermediate Similarity NPD6777 Approved
0.732 Intermediate Similarity NPD6778 Approved
0.732 Intermediate Similarity NPD6782 Approved
0.7317 Intermediate Similarity NPD1240 Approved
0.731 Intermediate Similarity NPD6799 Approved
0.7305 Intermediate Similarity NPD2796 Approved
0.7305 Intermediate Similarity NPD2935 Discontinued
0.7296 Intermediate Similarity NPD7697 Approved
0.7296 Intermediate Similarity NPD7696 Phase 3
0.7296 Intermediate Similarity NPD7698 Approved
0.7287 Intermediate Similarity NPD8434 Phase 2
0.7286 Intermediate Similarity NPD8151 Discontinued
0.7283 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD1247 Approved
0.7273 Intermediate Similarity NPD6801 Discontinued
0.7259 Intermediate Similarity NPD7870 Phase 2
0.7259 Intermediate Similarity NPD7871 Phase 2
0.7246 Intermediate Similarity NPD3748 Approved
0.7245 Intermediate Similarity NPD6823 Phase 2
0.7238 Intermediate Similarity NPD3787 Discontinued
0.7236 Intermediate Similarity NPD7701 Phase 2
0.7235 Intermediate Similarity NPD4628 Phase 3
0.7235 Intermediate Similarity NPD8166 Discontinued
0.7212 Intermediate Similarity NPD1613 Approved
0.7212 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD7435 Discontinued
0.72 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD4749 Approved
0.7182 Intermediate Similarity NPD8127 Discontinued
0.7182 Intermediate Similarity NPD7199 Phase 2
0.7178 Intermediate Similarity NPD4908 Phase 1
0.7175 Intermediate Similarity NPD37 Approved
0.7169 Intermediate Similarity NPD1933 Approved
0.7151 Intermediate Similarity NPD4966 Approved
0.7151 Intermediate Similarity NPD4965 Approved
0.7151 Intermediate Similarity NPD4967 Phase 2
0.7143 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD2799 Discontinued
0.7143 Intermediate Similarity NPD1653 Approved
0.7135 Intermediate Similarity NPD8455 Phase 2
0.7135 Intermediate Similarity NPD7003 Approved
0.7129 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7129 Intermediate Similarity NPD7801 Approved
0.7129 Intermediate Similarity NPD7783 Phase 2
0.7128 Intermediate Similarity NPD7700 Phase 2
0.7128 Intermediate Similarity NPD7699 Phase 2
0.7118 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7104 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7102 Intermediate Similarity NPD7458 Discontinued
0.7101 Intermediate Similarity NPD5408 Approved
0.7101 Intermediate Similarity NPD5405 Approved
0.7101 Intermediate Similarity NPD5404 Approved
0.7101 Intermediate Similarity NPD5406 Approved
0.7091 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD2313 Discontinued
0.7091 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7079 Intermediate Similarity NPD7874 Approved
0.7079 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7074 Intermediate Similarity NPD7549 Discontinued
0.7069 Intermediate Similarity NPD2532 Approved
0.7069 Intermediate Similarity NPD2533 Approved
0.7069 Intermediate Similarity NPD2534 Approved
0.7062 Intermediate Similarity NPD6535 Approved
0.7062 Intermediate Similarity NPD6534 Approved
0.7059 Intermediate Similarity NPD2344 Approved
0.7056 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD2798 Approved
0.7041 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD4625 Phase 3
0.703 Intermediate Similarity NPD3027 Phase 3
0.7024 Intermediate Similarity NPD6651 Approved
0.7021 Intermediate Similarity NPD7685 Pre-registration
0.7021 Intermediate Similarity NPD7240 Approved
0.6994 Remote Similarity NPD1203 Approved
0.6994 Remote Similarity NPD1470 Approved
0.6983 Remote Similarity NPD6844 Discontinued
0.6978 Remote Similarity NPD919 Approved
0.6977 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6964 Remote Similarity NPD230 Phase 1
0.6941 Remote Similarity NPD4308 Phase 3
0.6923 Remote Similarity NPD6213 Phase 3
0.6923 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6212 Phase 3
0.6915 Remote Similarity NPD8319 Approved
0.6915 Remote Similarity NPD8320 Phase 1
0.6914 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6897 Remote Similarity NPD2309 Approved
0.6897 Remote Similarity NPD6190 Approved
0.689 Remote Similarity NPD2797 Approved
0.6886 Remote Similarity NPD411 Approved
0.6886 Remote Similarity NPD3268 Approved
0.6871 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6867 Remote Similarity NPD6832 Phase 2
0.6866 Remote Similarity NPD7680 Approved
0.6852 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6852 Remote Similarity NPD1201 Approved
0.6836 Remote Similarity NPD6273 Approved
0.6825 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6825 Remote Similarity NPD7907 Approved
0.6823 Remote Similarity NPD8053 Approved
0.6823 Remote Similarity NPD8054 Approved
0.6818 Remote Similarity NPD8090 Clinical (unspecified phase)
0.681 Remote Similarity NPD9717 Approved
0.6809 Remote Similarity NPD7177 Discontinued
0.6789 Remote Similarity NPD5953 Discontinued
0.6769 Remote Similarity NPD4287 Approved
0.6765 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6761 Remote Similarity NPD3300 Phase 2
0.675 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6748 Remote Similarity NPD1610 Phase 2
0.673 Remote Similarity NPD4111 Phase 1
0.673 Remote Similarity NPD4665 Approved
0.6721 Remote Similarity NPD4288 Approved
0.6719 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6707 Remote Similarity NPD2861 Phase 2
0.6707 Remote Similarity NPD1608 Approved
0.6707 Remote Similarity NPD9494 Approved
0.6706 Remote Similarity NPD4307 Phase 2
0.6704 Remote Similarity NPD920 Approved
0.6702 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6686 Remote Similarity NPD6859 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data